Ligand Pharmaceuticals Files 8-K on Financials
Ticker: LGNZZ · Form: 8-K · Filed: Feb 27, 2025 · CIK: 886163
| Field | Detail |
|---|---|
| Company | Ligand Pharmaceuticals Inc (LGNZZ) |
| Form Type | 8-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: LGND
TL;DR
LGND filed an 8-K on Feb 27, 2025, detailing financial results. Check it out.
AI Summary
Ligand Pharmaceuticals Inc. filed an 8-K on February 27, 2025, reporting on its Results of Operations and Financial Condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Jupiter, Florida.
Why It Matters
This filing provides crucial updates on Ligand Pharmaceuticals' financial performance and condition, which is essential for investors to assess the company's health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing (8-K) that does not appear to disclose any new material adverse events or significant changes.
Key Players & Entities
- LIGAND PHARMACEUTICALS INC (company) — Filer
- February 27, 2025 (date) — Date of earliest event reported
- Jupiter, Florida (location) — Address of principal executive offices
FAQ
What is the primary purpose of this Form 8-K filing?
The primary purpose of this Form 8-K filing is to report on Ligand Pharmaceuticals Inc.'s Results of Operations and Financial Condition, and to include Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on February 27, 2025.
Where are Ligand Pharmaceuticals Inc.'s principal executive offices located?
Ligand Pharmaceuticals Inc.'s principal executive offices are located at 555 Heritage Drive, Suite 200, Jupiter, Florida 33458.
What is Ligand Pharmaceuticals Inc.'s state of incorporation?
Ligand Pharmaceuticals Inc. is incorporated in Delaware.
What is the SIC code for Ligand Pharmaceuticals Inc.?
The Standard Industrial Classification (SIC) code for Ligand Pharmaceuticals Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding LIGAND PHARMACEUTICALS INC (LGNZZ).